SolasCure has initiated a new Phase II clinical trial, CLEANVLU2, to further the development of its investigational product, ...
Clinical Trials Arena on MSN12 天
SolasCure initiates Phase II trial of chronic wound treatment gelUK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...
SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...
News-Medical.Net on MSN13 天
SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound GelSOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...
The gel is designed to be a 'safe' debrider suitable ... in addressing all aspects of wound bed preparation, including debridement. As part of the community service, the trial is being conducted ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈